TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
0 hedge funds and large institutions have $0 invested in Therapix Biosciences Ltd. in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 7 closing their positions.
Holders
–
Holders Change
-7
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| 3 |
3
Millennium Management
New York
|
$0 |
| 4 |
4
Envestnet Asset Management
Chicago,
Illinois
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| – | -$271K | -436,189 | Closed |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$26K | -41,428 | Closed |
|
|
3
Millennium Management
New York
| – | -$9K | -14,200 | Closed |
|
|
4
Envestnet Asset Management
Chicago,
Illinois
| – | -$6K | -10,018 | Closed |
|